FDA finalizes BIMO electronic submission guidance
Regulatory NewsFerdous Al-Faruque
Biologics License Application (BLA)Biologics/ biosimilars/ vaccinesGuidanceNew Drug Application (NDA)PharmaceuticalsRegulatory Intelligence/PolicyUnited StatesUS Food and Drug Administration (FDA)